| Structure | Chemical Name | CAS | MF |
|
NUF2 protein
|
|
|
|
|
NUF1 protein
|
146706-20-9
|
|
|
|
NT-3 PRIMER PAIR
|
|
|
|
|
NTproBNP(1-76)
|
|
|
|
|
NT1 protein, Plasmodium falciparum
|
|
|
|
|
NTP Set (100 mM)
|
|
|
|
|
NTP Set, solution 100 mM
|
|
|
|
|
NT-PROBNP,MABANTI-
|
|
|
|
|
NTPs Set, solution 100 mM
|
|
|
|
Nt-rab5 protein
|
147995-31-1
|
C8H15NO6
|
|
N-[[trans-4-[(4,5-Dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]methanesulfonamide
|
304008-29-5
|
C19H25N3O2S3
|
|
N-trans-Feruloyl-3-methoxytyramine
|
78510-19-7
|
C19H21NO5
|
|
N-[trans-4-[2-(6-Cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-4-quinolinecarboxamide
|
215803-78-4
|
C28H30N4O
|
|
|
N-TRANS-COUMAROYLOCTOPAMINE
|
|
|
|
|
N-TRANS-FERULOYLOCTOPAMINE
|
|
|
|
|
N-trans-2-((2-(acetylamino)cyclohexyl)acetyl)-alanyl-glutamic acid
|
|
|
|
N-TRANS-CINNAMOYLIMIDAZOLE
|
1138-15-4
|
C12H10N2O
|
|
N-(TRANS-4-TERT-BUTYL-CYCLOHEXYL)CARBONYL-D-PHENYLALANINE
|
105746-46-1
|
C20H29NO3
|
|
N-(TRANS-4-HYDROXYCYCLOHEXYL)2-NITROBENZYLAMINE HCL
|
|
C13H19ClN2O3
|
|
N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine
|
105746-37-0
|
C19H27NO3
|
|
(+/-) N-TRANS[ETHOXY CARBONMETHYL]-1-PHENYLETHYLAMINE
|
56720-98-0
|
C12H17NO2
|
|
|
[15N]TRANS-ZEATIN 98% (HPLC)
|
|
|
|
N-Trans-Feruloyltyramine
|
66648-43-9
|
C18H19NO4
|
|
N-trans-Cinnamoyltyramine
|
|
C17H17NO2
|
|
N-[TRANS-4-(SUCCINIMIDYLOXYCARBONYL)CYCLOHEXYLMETHYL]-SULFORHODAMINE B-ACID AMIDE
|
|
C35H38N4O10S2
|
|
|
N-(trans-3-Hydroxycotinine)-b-D-glucuronidemethyl-D3
|
|
|
|
|
N-(trans-3-Hydroxycotinine)-b-D-glucuronide
|
|
|
|
trans-Zeatin-riboside
|
6025-53-2
|
C15H21N5O5
|
|
N-trans-BOC-(3S)-Fluoropyrrolidine
|
479253-00-4
|
C9H16FNO2
|
|
N-TRANS-CINNAMOYLIMIDAZOLE
|
2979-51-3
|
C12H10N2O
|
|
N-trans-Cinnamoyl-N-phenyl-1-pyrrolidinecarbothioamide
|
|
C20H20N2OS
|
|
N-trans-Cinnamoyl-N-phenyl-4-morpholinecarbothioamide
|
|
C20H20N2O2S
|
|
N-trans-Cinnamoyl-N-phenyl-1-piperidinecarbothioamide
|
|
C21H22N2OS
|
|
N-trans-Cinnamoyl-N-phenyl-10H-phenothiazine-10-carbothioamide
|
|
C28H20N2OS2
|
|
NT2 purpurin
|
99128-91-3
|
C41H52N4O2
|
|
NT1 purpurin
|
107634-78-6
|
C41H50N4O2
|
|
|
ntrB protein, Rhizobium
|
|
|
|
|
ntrC protein, Rhizobium
|
|
|
|
|
NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2)
|
|
|
|
|
NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2) A
|
|
|
|
|
NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2, Nerve growth factor-2)
|
|
|
|
|
NT-4, Recombinant, Human (Neurotrophin 4)
|
|
|
|
|
NT-1, Recombinant, Human (Neurotrophin 1/B Cell Stimulating Factor 3, BCSF-3)
|
|
|
|
|
NT-3, Recombinant, Human (Neurotrophin 3, HDNF, NGF-2) B
|
|
|
|
|
NT-4, Recombinant, Human (Neurotrophin 4) A
|
|
|
|
|
Nug1 protein
|
|
|
|
n-Triacontane Solution
|
|
C30H62
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-3,4-dihydro-2H-1-benzopyran-4-amine
|
|
C16H16N4O
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclopentanamine
|
|
C13H18N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1-azabicyclo[2.2.2]octan-3-amine
|
|
C14H19N5
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}thiolan-3-amine
|
|
C11H14N4S
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-2,3-dihydro-1H-inden-1-amine
|
|
C16H16N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-3,4-dihydro-2H-1-benzothiopyran-4-amine
|
|
C16H16N4S
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclohexanamine
|
|
C13H18N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cycloheptanamine
|
|
C14H20N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1,4-dioxaspiro[4.5]decan-8-amine
|
|
C15H20N4O2
|
|
N1-[4-(1,4,5-triazatricyclo[5.2.2.0~2,6~]undec-5-en-3-yl)phenyl]acetamide
|
|
C16H20N4O
|
|
N-[1,2,4]triazolo[1,5-a]pyridin-8-ylmethanesulfonamide
|
400081-70-1
|
C7H8N4O2S
|
|
N-[1,2,4]triazolo[1,5-a]pyridin-8-ylcyclopropanecarboxamide
|
400081-71-2
|
C10H10N4O
|
|
N-1,2,4-TRIAZIN-3-YLTHIOUREA
|
|
C4H5N5S
|
|
N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YLPENTANAMIDE
|
338419-03-7
|
C11H14N4O
|
|
N-TRIACONTANE
|
638-68-6
|
C30H62
|
|
N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YL-3-(TRIFLUOROMETHYL)BENZENECARBOXAMIDE
|
338419-02-6
|
C14H9F3N4O
|
|
N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YL-1,2,3-THIADIAZOLE-4-CARBOXAMIDE
|
|
C9H6N6OS
|
|
N-TRIACONTANE-D62
|
93952-07-9
|
C30D62
|
|
N-TRIACONTYLTRICHLOROSILANE
|
70851-48-8
|
C30H61Cl3Si
|
|
N-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-8-YLBENZENECARBOXAMIDE
|
338406-04-5
|
C13H10N4O
|
|
1-[N-(1,2,4-TRIAZOL-4-YL)AMINO]-2-(TRIFLUOROACETYL)CYCLOHEX-1-ENE
|
|
C10H11F3N4O
|
|
N-1,3,5-TRIAZIN-2-YLTHIOUREA
|
|
C4H5N5S
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclohexanamine
|
|
C14H20N4
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)thiolan-3-amine
|
|
C12H16N4S
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cyclooctanamine
|
|
C16H24N4
|
|
|
N-[γ-Trialkoxy(C=12)silylpropyl]-N-(β-aminoethyl)amine
|
|
|
|
|
N-(γ-Trialkoxysilylpropyl)-N-(N'-alkyl-β-aminoethyl)ammonium[salt alkoxy(C=12),alkyl(C=120),acid residue(Cl,Br,I,CH3COO)]
|
|
|
|
N-([1,2,4]triazolo[1,5-a]pyrimidin-2-ylcarbonyl)glycine
|
|
C8H7N5O3
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)cycloheptanamine
|
|
C15H22N4
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)-2,3-dihydro-1H-inden-1-amine
|
|
C17H18N4
|
|
N-(3-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-ylphenyl)-2-thiophenecarboxamide
|
879055-48-8
|
C14H9N5OS2
|
|
N-(2-{[1,2,4]triazolo[3,4-a]pyridin-3-yl}ethyl)-1-azabicyclo[2.2.2]octan-3-amine
|
|
C15H21N5
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclooctanamine
|
|
C15H22N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}-1,2,3,4-tetrahydronaphthalen-1-amine
|
|
C17H18N4
|
|
N-{[1,2,4]triazolo[3,4-a]pyridin-3-ylmethyl}cyclopentanamine
|
|
C12H16N4
|
|
N-(2,4,6-tribromophenyl)-octahydro-1H-indole-2-carboxamide
|
|
C15H17Br3N2O
|
|
N-(2,4,6-tribromophenyl)-1,4-dioxaspiro[4.5]decan-8-amine
|
|
C14H16Br3NO2
|
|
N-(2,4,6-tribromophenyl)piperazine-1-sulfonamide
|
|
C10H12Br3N3O2S
|
|
N-(2,4,6-tribromophenyl)-3,4-dihydro-2H-1-benzopyran-4-amine
|
|
C15H12Br3NO
|
|
N-(2,4,6-tribromophenyl)piperidine-2-carboxamide
|
|
C12H13Br3N2O
|
|
N-(2,4,6-tribromophenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine
|
|
C10H9Br3N2S
|
|
N-[2-(2,4,6-tribromophenoxy)ethyl]cyclopropanamine
|
|
C11H12Br3NO
|
|
N-[3-(2,4,6-tribromophenoxy)propyl]cyclopropanamine
|
|
C12H14Br3NO
|
|
N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZENE-1-SULFONAMIDE
|
|
C15H9Br3ClN3O2S
|
|
N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZAMIDE
|
|
C16H9Br3ClN3O
|
|
N1-[2-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)ETHYL]-4-CHLOROBENZENE-1-SULFONAMIDE
|
|
C11H9Br3ClN3O2S
|
|
N-(2,4,6-tribromophenyl)acetamide
|
607-93-2
|
C8H6Br3NO
|
|
N1-[2-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)ETHYL]-4-CHLOROBENZENE-1-SULPHONAMIDE
|
|
C11H9Br3ClN3O2S
|
|
N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]-4-CHLOROBENZENE-1-SULPHONAMIDE
|
|
C15H9Br3ClN3O2S
|
|
N-(2,4,6-tribromophenyl)formamide
|
72002-23-4
|
C7H4Br3NO
|
|
N-[3-(tributoxysilyl)propyl]ethylenediamine
|
51895-55-7
|
C17H40N2O3Si
|
|
N1-[4-(3,4,5-TRIBROMO-1H-PYRAZOL-1-YL)PHENYL]ACETAMIDE
|
|
C11H8Br3N3O
|
|
|
N-(TRIBROMOPHOSPHINO)-N,N-DIMETHYL-AMINOMETHYL POLYSTYRENE (16-50 MESH, 1.0-1.5 MMOL/G)
|
|
|